NUCLEOSIDE TRANSPORTERS: CNTs AND ENTs - Drug Transporters: Molecular Characterization and Role in Drug Disposition - page 194

48. Yao SY, Ng AM, Loewen SK, Cass CE, Baldwin SA, Young JD. 2002. An ancient
prevertebrate Na + -nucleoside cotransporter (hfCNT) from the Pacific hagfish ( Eptatretus
stouti ). Am J Physiol Cell Physiol 283(1):C155-C168.
49. Molina-Arcas M, Bellosillo B, Casado FJ, Montserrat E, Gil J, Colomer D, Pastor-Anglada
M. 2003. Fludarabine uptake mechanisms in B-cell chronic lymphocytic leukemia. Blood
101(6):2328-2334.
50. Toan SV, To KK, Leung GP, de Souza MO, Ward JL, Tse CM. 2003. Genomic organiza-
tion and functional characterization of the human concentrative nucleoside transporter-3
isoform (hCNT3) expressed in mammalian cells. Pflugers Arch 447(2):195-204.
51. Hu H, Endres CJ, Chang C, Umapathy NS, Lee EW, Fei YJ, Itagaki S, Swaan PW,
Ganapathy V, Unadkat JD. 2006. Electrophysiological characterization and modeling of
the structure activity relationship of the human concentrative nucleoside transporter 3
(hCNT3). Mol Pharmacol 69(5):1542-1553.
52. Smith KM, Ng AM, Yao SY, Labedz KA, Knaus EE, Wiebe LI, Cass CE, Baldwin
SA, Chen XZ, Karpinski E, Young JD. 2004. Electrophysiological characterization of a
recombinant human Na + -coupled nucleoside transporter (hCNT1) produced in Xenopus
oocytes. J Physiol 558(Pt 3):807-823.
53. Smith KM, Slugoski MD, Loewen SK, Ng AM, Yao SY, Chen XZ, Karpinski E, Cass CE,
Baldwin SA, Young JD. 2005. The broadly selective human Na + /nucleoside cotransporter
(hCNT3) exhibits novel cation-coupled nucleoside transport characteristics. J Biol Chem
280(27):25436-25449.
54. Baldwin SA, Mackey JR, Cass CE, Young JD. 1999. Nucleoside transporters: molecular
biology and implications for therapeutic development. Mol Med Today 5(5):216-224.
55. Zhang J, Visser F, Vickers MF, Lang T, Robins MJ, Nielsen LP, Nowak I, Baldwin SA,
Young JD, Cass CE. 2003. Uridine binding motifs of human concentrative nucleoside
transporters 1 and 3 produced in Saccharomyces cerevisiae . Mol Pharmacol 64(6):1512-
1520.
56. Zhang J, Smith KM, Tackaberry T, Visser F, Robins MJ, Nielsen LP, Nowak I, Karpinski E,
Baldwin SA, Young JD, Cass CE. 2005. Uridine binding and transportability determinants
of human concentrative nucleoside transporters. Mol Pharmacol 68(3):830-839.
57. Lang TT, Young JD, Cass CE. 2004. Interactions of nucleoside analogs, caffeine, and
nicotine with human concentrative nucleoside transporters 1 and 2 stably produced in a
transport-defective human cell line. Mol Pharmacol 65(4):925-933.
58. Chang C, Swaan PW, Ngo LY, Lum PY, Patil SD, Unadkat JD. 2004. Molecular require-
ments of the human nucleoside transporters hCNT1, hCNT2, and hENT1. Mol Pharmacol
65(3):558-570.
59. Mangravite LM, Giacomini KM. 2003. Sorting of rat SPNT in renal epithelium is inde-
pendent of N-glycosylation. Pharm Res 20(2):319-323.
60. Wang J, Giacomini KM. 1997. Molecular determinants of substrate selectivity in Na + -
dependent nucleoside transporters. J Biol Chem 272(46):28845-28848.
61. Wang J, Giacomini KM. 1999. Serine 318 is essential for the pyrimidine selectivity of
the N2 Na + -nucleoside transporter. J Biol Chem 274(4):2298-2302.
62. Wang J, Giacomini KM. 1999. Characterization of a bioengineered chimeric Na + -
nucleoside transporter. Mol Pharmacol 55(2):234-240.
63. Loewen SK, Ng AM, Yao SY, Cass CE, Baldwin SA, Young JD. 1999. Identification of
amino acid residues responsible for the pyrimidine and purine nucleoside specificities of